Alembic’s $12M UK Bet: Utility Therapeutics Acquisition Boosts Antibiotic Portfolio

Unknown Apr 02, 2026 650 Views

Alembic Pharmaceuticals Ltd has made a strategic leap into the European infectious disease market by acquiring Utility Therapeutics Ltd, a UK-based specialty pharma firm, for $12 million. The acquisition was executed through Alembic’s wholly owned subsidiary and is aimed at strengthening it...